Global Ambassador Ni Luh Putu Harta Wedari Represents AMI at ICAC 2024

AMI Strengthens Global Presence at the 33rd International Congress of Antimicrobial Chemotherapy

Applied Microbiology International (AMI) continued to expand its global visibility at the 33rd International Congress of Antimicrobial Chemotherapy (ICAC), held at the Istanbul Congress Center, Türkiye, from 3–6 November 2024. The event gathered leading scientists, clinicians, and researchers to discuss the latest developments in antimicrobial resistance, infection control, and innovative therapeutic strategies.

The congress featured plenary lectures, keynote addresses, symposia, and workshops led by world-renowned experts, offering participants an invaluable opportunity to exchange ideas, forge collaborations, and strengthen networks across disciplines.
Explore the full scientific programme.

Showcasing AMI in the Scientific Arena

As AMI’s Global Ambassador for Indonesia, I presented a poster titled:
“Relationship Between tcdA and tcdB Genes of Clostridium difficile With Diarrhea Duration in Elderly Patients: An Immunosenescence Effect.”

Throughout the session, I introduced AMI’s mission and activities to attendees, emphasizing our organization’s commitment to advancing microbial sciences worldwide.

During the congress, I had the opportunity to promote AMI’s work and explore potential collaborations with key figures from the International Society of Antimicrobial Chemotherapy (ISAC):

• Prof. Andreas Voss, Former ISAC President – discussed AMI’s role and the potential for bridging AMI and ISAC initiatives.

• Prof. Souha Kanj, Current ISAC President – explored opportunities for collaboration, particularly through ISAC’s Clostridium difficile Infection (CDI) Working Group. Given the current underrepresentation of CDI research, both parties recognized the potential for AMI to play an active role in revitalizing this important field.

Fostering Academic and Professional Connections

Further conversations with Prof. Adrian Egli of the Institute of Medical Microbiology, University of Zurich, and his colleagues, highlighted opportunities for research collaboration and knowledge exchange. Prof. Egli expressed strong interest in AMI’s global ambassador program and potential future joint activities.

In addition, through ongoing communication with Fiona Johnstone (Fee), Executive Officer at ISAC, I progressed my involvement in the CDI Working Group Committee—offering a sustained platform to promote AMI’s engagement and visibility in this critical research area.

Finally, I introduced AMI to new international colleagues, including two delegates from Japan, with whom I plan to maintain collaboration on shared research interests.

A Growing Global Network

The 33rd ICAC provided an excellent opportunity to represent AMI on the global stage, promote its mission, and establish new academic and organizational partnerships. Through these interactions, AMI’s profile continues to grow within the international antimicrobial research community, strengthening our shared commitment to tackling microbial challenges worldwide.